Deranged Thyroid Hormone Status in Non-Thyroid Illnesses
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Hyperthyroidism
135 Review Article Hyperthyroidism Amanda R. Doubleday, Rebecca S. Sippel Division of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Rebecca S. Sippel, MD. Division of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Clinical Science Center-H4/722, Box 7375, 600 Highland Ave, Madison, WI 53792-3284, USA. Email: [email protected]; Amanda R. Doubleday, DO, MBA. Division of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, K4/739 Clinical Science Center, 600 Highland Ave, Madison, WI 53792-3284, USA. Email: [email protected]. Abstract: Hyperthyroidism is a condition where the thyroid gland produces and secretes inappropriately high amounts of thyroid hormone which can lead to thyrotoxicosis. The prevalence of hyperthyroidism in the United States is approximately 1.2%. There are many different causes of hyperthyroidism, and the most common causes include Graves’ disease (GD), toxic multinodular goiter and toxic adenoma. The diagnosis can be made based on clinical findings and confirmed with biochemical tests and imaging techniques including ultrasound and radioactive iodine uptake scans. This condition impacts many different systems of the body including the integument, musculoskeletal, immune, ophthalmic, reproductive, gastrointestinal and cardiovascular systems. It is important to recognize common cardiovascular manifestations such as hypertension and tachycardia and to treat these patients with beta blockers. -
Management of Graves Disease:€€A Review
Clinical Review & Education Review Management of Graves Disease A Review Henry B. Burch, MD; David S. Cooper, MD Author Audio Interview at IMPORTANCE Graves disease is the most common cause of persistent hyperthyroidism in adults. jama.com Approximately 3% of women and 0.5% of men will develop Graves disease during their lifetime. Supplemental content at jama.com OBSERVATIONS We searched PubMed and the Cochrane database for English-language studies CME Quiz at published from June 2000 through October 5, 2015. Thirteen randomized clinical trials, 5 sys- jamanetworkcme.com and tematic reviews and meta-analyses, and 52 observational studies were included in this review. CME Questions page 2559 Patients with Graves disease may be treated with antithyroid drugs, radioactive iodine (RAI), or surgery (near-total thyroidectomy). The optimal approach depends on patient preference, geog- raphy, and clinical factors. A 12- to 18-month course of antithyroid drugs may lead to a remission in approximately 50% of patients but can cause potentially significant (albeit rare) adverse reac- tions, including agranulocytosis and hepatotoxicity. Adverse reactions typically occur within the first 90 days of therapy. Treating Graves disease with RAI and surgery result in gland destruction or removal, necessitating life-long levothyroxine replacement. Use of RAI has also been associ- ated with the development or worsening of thyroid eye disease in approximately 15% to 20% of patients. Surgery is favored in patients with concomitant suspicious or malignant thyroid nodules, coexisting hyperparathyroidism, and in patients with large goiters or moderate to severe thyroid Author Affiliations: Endocrinology eye disease who cannot be treated using antithyroid drugs. -
Newborn Screening for Congenital Hypothyroidism: Recommended Guidelines
American Academy of Pediatrics American Thyroid Association Newborn Screening for Congenital Hypothyroidism: Recommended Guidelines During the past decade newborn screening for of identifying newborns with hyperthyroxinemia congenital hypothyroidism has become an impor- (1:20,000 to 40,000 newborns). tant health activity in most developed countries. On the other hand, this approach will miss in- These screening programs have not only benefited fants who have normal T4 values but elevated TSH patients and their families but also have produced values. Such infants are relatively commonplace in new information about the epidemiology, patho- European programs where initial screening is done physiology, diagnosis, and treatment of thyroid dis- by measurement of TSH. To identify such infants, ease in infancy and childhood. During this period the T4 concentration cutoff (for TSH testing) must of implementation and growth of the screening be increased well into the normal range. programs, a variety of issues and questions arose. Some of these have been resolved, and some have TSH not. The point has now been reached where colla- A majority of European and Japanese programs tion of the combined experiences of the North favor screening by means of primary TSH mea- American programs can address these issues. The surements, supplemented by T4 determinations on reader should understand that what follows reflects those infants with elevated TSH values. With this 0 current opinion and may require changes when the approach, infants with thyroxine-binding globulin results of the next decade of screening are reviewed. deficiency, hypo- or hyperthyroxinemia, or hypo- thalamic-pituitary hypothyroidism will be missed. SCREENING METHOD Until further advances are made in the state of the art of screening, the choice ofthe method should Thyroxine (T4) and Thyroid-Stimulating Hormone be based on the experience of the program, needs (TSH) of the population, and availability of resources. -
Familial Dysalbuminemic Hyperthyroxinemia: an Underdiagnosed Entity
Journal of Clinical Medicine Article Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity Xavier Dieu 1,2,* , Nathalie Bouzamondo 1,3, Claire Briet 2,3,4 , Frédéric Illouz 3,4, Valérie Moal 1,3, Florence Boux de Casson 1,3, Natacha Bouhours-Nouet 3,5, Pascal Reynier 1 , Régis Coutant 3,5, Patrice Rodien 2,3,4 and Delphine Mirebeau-Prunier 1,2,3 1 Laboratoire de Biochimie et Biologie Moléculaire, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France; [email protected] (N.B.); [email protected] (V.M.); [email protected] (F.B.d.C.); [email protected] (P.R.); [email protected] (D.M.-P.) 2 UMR CNRS 6015-INSERM U1083, 3 rue Roger Amsler, 49100 Angers, France; [email protected] (C.B.); [email protected] (P.R.) 3 Centre de référence des maladies rares de la thyroïde et des récepteurs hormonaux, CHU Angers, 4 rue Larrey, CEDEX 9,49933 Angers, France; [email protected] (F.I.); [email protected] (N.B.-N.); [email protected] (R.C.) 4 Service d’Endocrinologie-Diabétologie-Nutrition, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France 5 Service d’Endocrinologie et Diabétologie Pédiatrique, CHU Angers, 4 rue Larrey, CEDEX 9, 49933 Angers, France * Correspondence: [email protected] Received: 5 May 2020; Accepted: 29 June 2020; Published: 3 July 2020 Abstract: Resistance to thyroid hormone (RTH) is a syndrome characterized by impaired sensitivity of tissues to thyroid hormone (TH). The alteration of TH-binding proteins, such as in Familial Dysalbuminemic Hyperthyroxinemia (FDH), can mimic the abnormal serum thyroid tests typical of RTH. -
Hypothyroidism: Mimicker of Common Complaints Matthew C
Emerg Med Clin N Am 23 (2005) 649–667 Hypothyroidism: Mimicker of Common Complaints Matthew C. Tews, DOa, Sid M. Shah, MD, FACEPb,*, Ved V. Gossain, MD, FACP, FACEPc aCollege of Osteopathic Medicine, Emergency Medicine Residency Program, Michigan State University–Lansing, P.O. Box 30480, Lansing, MI 48909, USA bMichigan State University, Attending Physician Emergency Medicine, Ingham Regional Medical, Center 401 W. Greenlawn Avenue, Lansing, MI 48910, USA cDivision of Endocrinology, Department of Medicine, Michigan State University, Lansing, MI 48909, USA Patients with hypothyroidism may present with vague symptoms such as fatigue, arthralgias, myalgias, muscle cramps, headaches, and ‘‘not feeling well.’’ These are also among the more common complaints encountered by the emergency physicians. The disease spectrum of hypothyroidism ranges from an asymptomatic, subclinical condition to the rare, life-threatening myxedema coma, and thus can be a challenging diagnosis to make. A progressive and chronic disease, hypothyroidism results from diminished thyroid hormone production. It slows metabolic functions in every organ system in the body. Commonly, clinical presentation of hypothyroidism can be confused with effects of aging in the elderly, musculoskeletal or a psychiatric illness such as depression in the younger patients. Spontaneously occurring hypothyroidism is relatively common, with prevalence between 1% to 2%, and is 10 times more common in women than in men [1]. The probability of developing spontaneous hypothyroidism increases with age, with women having a mean age at diagnosis of around 60 years [2]. A recent survey showed that 9.5% out of nearly 26,000 visitors to a statewide health fair in Colorado had elevated circulating thyroid stimulating hormone (TSH) levels, indicating underlying hypothyroidism [3]. -
Thyroid Emergencies
REVIEW ARTICLE Thyroid emergencies Dorina Ylli1, Joanna Klubo ‑Gwiezdzinska2, Leonard Wartofsky3,4 1 Endocrinology Division, University of Medicine, Tirana, Albania 2 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States 3 Endocrinology Division, Department of Medicine, Georgetown University School of Medicine, Washington DC, United States 4 MedStar Health Research Institute, MedStar Washington Hospital Center, Washington DC, United states KEY WORDS ABSTRACT coma, critical care, Myxedema coma and thyroid storm are among the most common endocrine emergencies presenting to hypothermia, general hospitals. Myxedema coma represents the most extreme, life ‑threatening expression of severe hypothyroidism, hypothyroidism, with patients showing deteriorating mental status, hypothermia, and multiple organ thyrotoxicosis system abnormalities. It typically appears in patients with preexisting hypothyroidism via a common pathway of respiratory decompensation with carbon dioxide narcosis leading to coma. Without early and appropriate therapy, the outcome is often fatal. The diagnosis is based on history and physical find‑ ings at presentation and not on any objective thyroid laboratory test. Clinically based scoring systems have been proposed to aid in the diagnosis. While it is a relatively rare syndrome, the typical patient is an elderly woman (thyroid hypofunction being much more common in women) who may or may not have a history of previously diagnosed or treated thyroid dysfunction. Thyrotoxic storm or thyroid crisis is also a rare condition, established on the basis of a clinical diagnosis. The diagnosis is based on the pres‑ ence of severe hyperthyroidism accompanied by elements of systemic decompensation. Considering that mortality is high without aggressive treatment, therapy must be initiated as early as possible in a critical care setting. -
Endocrine Test Selection and Interpretation
The Quest Diagnostics Manual Endocrinology Test Selection and Interpretation Fourth Edition The Quest Diagnostics Manual Endocrinology Test Selection and Interpretation Fourth Edition Edited by: Delbert A. Fisher, MD Senior Science Officer Quest Diagnostics Nichols Institute Professor Emeritus, Pediatrics and Medicine UCLA School of Medicine Consulting Editors: Wael Salameh, MD, FACP Medical Director, Endocrinology/Metabolism Quest Diagnostics Nichols Institute San Juan Capistrano, CA Associate Clinical Professor of Medicine, David Geffen School of Medicine at UCLA Richard W. Furlanetto, MD, PhD Medical Director, Endocrinology/Metabolism Quest Diagnostics Nichols Institute Chantilly, VA ©2007 Quest Diagnostics Incorporated. All rights reserved. Fourth Edition Printed in the United States of America Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. All third party marks − ®' and ™' − are the property of their respective owners. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, and information storage and retrieval system, without permission in writing from the publisher. Address inquiries to the Medical Information Department, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA 92690-6130. Previous editions copyrighted in 1996, 1998, and 2004. Re-order # IG1984 Forward Quest Diagnostics Nichols Institute has been -
ATA/AACE Guidelines
ATA/AACE Guidelines CLINICAL PRACTICE GUIDELINES FOR HYPOTHYROIDISM IN ADULTS: COSPONSORED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN THYROID ASSOCIATION Jeffrey R. Garber, MD, FACP, FACE1,2*; Rhoda H. Cobin, MD, FACP, MACE3; Hossein Gharib, MD, MACP, MACE4; James V. Hennessey, MD, FACP2; Irwin Klein, MD, FACP5; Jeffrey I. Mechanick, MD, FACP, FACE, FACN6; Rachel Pessah-Pollack, MD6,7; Peter A. Singer, MD, FACE8; Kenneth A. Woeber, MD, FRCPE9 for the American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice are systematically developed statements to assist health-care professionals in medical decision making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied. These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. The presented recommendations may not be appropriate in all situations. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances. 988 989 CLINICAL PRACTICE GUIDELINES FOR HYPOTHYROIDISM IN ADULTS: COSPONSORED BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN THYROID ASSOCIATION Jeffrey R. Garber, MD, FACP, FACE1,2*; Rhoda H. Cobin, MD, FACP, MACE3; Hossein Gharib, MD, MACP, MACE4; James V. Hennessey, MD, FACP2; Irwin Klein, MD, FACP5; Jeffrey I. Mechanick, MD, FACP, FACE, FACN6; Rachel Pessah-Pollack, MD6,7; Peter A. -
Impaired Sensitivity to Thyroid Hormones Is Associated With
Diabetes Care 1 Impaired Sensitivity to Thyroid Martin Laclaustra,1,2,3 Belen Moreno-Franco,1,2 Hormones Is Associated With Jose Manuel Lou-Bonafonte,1,4,5 Rocio Mateo-Gallego,1,2 Diabetes and Metabolic Syndrome Jose Antonio Casasnovas,1,2 Pilar Guallar-Castillon,6,7,8 Ana Cenarro,1,2 1,2 https://doi.org/10.2337/dc18-1410 and Fernando Civeira OBJECTIVE Diabetes prevalence and incidence increase among individuals with hypothyroidism but also among those with hyperthyroxinemia, which seems contradictory. Both high free thyroxine (fT4) and high thyroid-stimulating hormone (TSH) are present in the resistance to thyroid hormone syndrome. A mild acquired resistance to thyroid hormone might occur in the general population and be associated with diabetes. We aimed to analyze the association of resistance to thyroid hormone indices (the Thyroid Feedback Quantile-based Index [TFQI], proposed in this work, and the previously used Thyrotroph T4 Resistance Index and TSH Index) with diabetes. RESEARCH DESIGN AND METHODS 1Instituto de Investigacion´ Sanitaria de Aragon´ We calculated the aforementioned resistance to thyroid hormone indices based on (IIS Aragon),´ Universidad de Zaragoza, Zaragoza, ‡ Spain a U.S. representative sample of 5,129 individuals 20 years of age participating in 2Translational Research Unit, Hospital Univer- the 2007–2008 National Health and Nutrition Examination Survey (NHANES). Also, sitario Miguel Servet, Zaragoza, Spain and to approximate TFQI, a U.S.-referenced Parametric TFQI (PTFQI) can be calculated CIBERCV, Madrid, Spain 3 CARDIOVASCULAR AND METABOLIC RISK with the spreadsheet formula 5NORM.DIST(fT4_cell_in_pmol_per_L,10.075, Fundacion´ Agencia Aragonesa para la Inves- 1 2 tigacion´ y el Desarrollo (ARAID), Zaragoza, Spain 2.155,TRUE) NORM.DIST(LN(TSH_cell_in_mIU_per_L),0.4654,0.7744,TRUE) 1. -
Some Aspects of Thyroid System Status in Persons Exposed to the Chernobyl Accident
IAEA-CN-67/18 XA9745557 SOME ASPECTS OF THYROID SYSTEM STATUS IN PERSONS EXPOSED TO THE CHERNOBYL ACCIDENT Anatoly K.Cheban, Dmitry E.Afanasyev, Olga Y.Boyarskaya Paediatric Endocrinology Department, Endocrinology Departmant Radiation Medicine Scientific Centre of Ukrainian Medical Sciences Academy Melnikova str. No53, Kiev 254050, Ukraine ABSTRACT The thyroid system status estimation held in post-accidental period dynamics among 7868 children evacuated from the 30-km Chernobyl zone and resident now in Slavutich city (Cs-137 contaminated area), among contaminated regions permanent residents, among native kievites and evacuated from 30-km zone. The thyroid pathology incidence dependence on residence place during Chernobyl Accident and after that was revealed. The immune-inflammatory thyroid disorders are characteristic for 30-km zone migrants, goitre different forms - for the radionuclides contaminated territories residents. No thyroid function abnormalities frequency confidential increase was registered during the research activities run. The total serum cholesterol level application unavailability is revealed in Chernobyl accident survivors thyroid hormones metabolic effects estimation. Data concerning Chernobyl accident consequences cleaning up participants (CACCP) presented additionally. INTRODUCTION The thyroid gland and thyroid system in general posses the important place among nuclear facilities accidents. That is particular in case of Chernobyl nuclear power plant accident (CNPPA) [1]. Because of radioiodine high content in CNPPA fallout and iodine metabolism features the thyroid irradiation doses can exceed 10 - 20 Gy [2]. That unavoidably leads to thyroid pathology risk amplification [3]. Children are characteristic with higher thyroid irradiation doses compared to that in adults [4]. The radioecologic situation after the CNPPA in Ukraine is peculiar with extreme irregularity of present soil contamination level and radioiodine-produced thyroid irradiation doses in 1986. -
NOTE a Case of Graves' Disease with Anti-Triiodothyronine Antibodies The
Endocrinol. Japon. 1985, 32 (1), 181-188 NOTE A Case of Graves' Disease with Anti-triiodothyronine Antibodies SHIGEKI SAKATA, TAKASHI KOMAKI, SHIGENORI NAKAMURA, KEITA KAMIKUBO, KAORU TAKAKUWA*, MASAAKI KAMETANI*, NAOKI TOKIMITSU*, AND KIYOSHI MIURA The Third Department of Internal Medicine, Gifu University School of Medicine, Gifu 500 *Department of Internal Medicine, Takayama Red Cross Hospital, Takayama 504 Abstract A case of Graves' disease with high serum thyroxine (T4) and low triiodo- thyronine (T3) levels which was therefore initially diagnosed as a T4-thyrotoxi- cosis is reported. Examination of the serum from the patient showed the presence of unusual protein which bound T3. It was later confirmed as IgG class anti-T3 anti- bodies. In addition to treatment with methylmercaptoimidazole (MMI), the patient was treated with prednisolone for 30 days (total amount 500mg). Titers of and-T3 antibodies in the sera were unchanged before and after prednisolone treatment. Our present case indicates that it is clinically important to bear the presence of autoantibodies in mind to account for a possible error in measuring T3 and T4 by radioimmunoassay (RIA). In the case that RIA determination gives an unexpectedly high or low T3 and/or T4 value, the presence of autoantibodies to them should be considered and a test for them is recommended. Circulating autoantibodies to thyroid mone in Hashimoto's thyroiditis. The ac- hormone have been reported in various cumulation of reports up to the present sug- thyroidal (Robbins et al., 1956; Ikekubo et gest that the spontaneous occurrence of al., 1978; Ginsberg et al., 1878; Jcbrgensen antibodies to T4 and/or T3 in man may not et al., 1979; Inada et al., 1980; Pearce et be a rare phenomenon, especially in patients al., 19 81) and nonthyroidal illnesses (Tri- with Hashimoto's thyroiditis. -
Test Selection and Interpretation the Quest Diagnostics
The Quest Diagnostics Manual Endocrinology Test Selection and Interpretation Fourth Edition The Quest Diagnostics Manual Endocrinology Test Selection and Interpretation Fourth Edition Edited by: Delbert A. Fisher, MD Senior Science Officer Quest Diagnostics Nichols Institute Professor Emeritus, Pediatrics and Medicine UCLA School of Medicine Consulting Editors: Wael Salameh, MD, FACP Medical Director, Endocrinology/Metabolism Quest Diagnostics Nichols Institute San Juan Capistrano, CA Associate Clinical Professor of Medicine, David Geffen School of Medicine at UCLA Richard W. Furlanetto, MD, PhD Medical Director, Endocrinology/Metabolism Quest Diagnostics Nichols Institute Chantilly, VA ©2007 Quest Diagnostics Incorporated. All rights reserved. Fourth Edition Printed in the United States of America Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. All third party marks − ®' and ™' − are the property of their respective owners. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, and information storage and retrieval system, without permission in writing from the publisher. Address inquiries to the Medical Information Department, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA 92690-6130. Previous editions copyrighted in 1996, 1998, and 2004. Re-order # IG1984 Forward Quest Diagnostics Nichols Institute has been